Simulations Plus Price to Free Cash Flow Ratio 2010-2024 | SLP
Historical price to free cash flow ratio values for Simulations Plus (SLP) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Simulations Plus Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-11-19 |
27.62 |
|
58.65 |
| 2024-08-31 |
36.25 |
$0.47 |
76.98 |
| 2024-05-31 |
48.17 |
$2.73 |
17.62 |
| 2024-02-29 |
41.38 |
$0.67 |
61.37 |
| 2023-11-30 |
39.03 |
$0.68 |
57.68 |
| 2023-08-31 |
44.22 |
$0.89 |
49.77 |
| 2023-05-31 |
43.87 |
$1.12 |
39.12 |
| 2023-02-28 |
37.71 |
$0.88 |
42.72 |
| 2022-11-30 |
40.18 |
$0.74 |
53.99 |
| 2022-08-31 |
59.35 |
$0.67 |
88.40 |
| 2022-05-31 |
46.88 |
$0.67 |
69.87 |
| 2022-02-28 |
38.85 |
$0.68 |
57.41 |
| 2021-11-30 |
46.25 |
$0.60 |
77.23 |
| 2021-08-31 |
43.56 |
$0.71 |
61.77 |
| 2021-05-31 |
51.83 |
$0.59 |
88.24 |
| 2021-02-28 |
70.37 |
$0.53 |
133.91 |
| 2020-11-30 |
54.87 |
$0.55 |
100.44 |
| 2020-08-31 |
58.36 |
$0.45 |
129.92 |
| 2020-05-31 |
49.59 |
$0.43 |
114.10 |
| 2020-02-29 |
31.82 |
$0.42 |
75.71 |
| 2019-11-30 |
32.60 |
$0.53 |
61.69 |
| 2019-08-31 |
35.16 |
$0.54 |
65.25 |
| 2019-05-31 |
24.37 |
$0.50 |
48.89 |
| 2019-02-28 |
19.89 |
$0.49 |
40.47 |
| 2018-11-30 |
19.16 |
$0.40 |
48.18 |
| 2018-08-31 |
20.09 |
$0.39 |
51.57 |
| 2018-05-31 |
18.44 |
$0.32 |
57.80 |
| 2018-02-28 |
14.89 |
$0.40 |
36.81 |
| 2017-11-30 |
14.83 |
$0.33 |
45.55 |
| 2017-08-31 |
13.78 |
$0.30 |
45.39 |
| 2017-05-31 |
11.56 |
$0.34 |
33.60 |
| 2017-02-28 |
9.11 |
$0.30 |
30.75 |
| 2016-11-30 |
8.87 |
$0.37 |
23.72 |
| 2016-08-31 |
8.05 |
$0.24 |
33.13 |
| 2016-05-31 |
7.09 |
$0.28 |
24.89 |
| 2016-02-29 |
8.83 |
$0.29 |
30.38 |
| 2015-11-30 |
8.20 |
$0.32 |
26.00 |
| 2015-08-31 |
6.16 |
$0.35 |
17.80 |
| 2015-05-31 |
5.35 |
$0.27 |
19.60 |
| 2015-02-28 |
5.71 |
$0.25 |
23.29 |
| 2014-11-30 |
5.67 |
$0.17 |
32.59 |
| 2014-08-31 |
5.94 |
$0.24 |
24.93 |
| 2014-05-31 |
5.30 |
$0.18 |
29.82 |
| 2014-02-28 |
4.96 |
$0.14 |
35.45 |
| 2013-11-30 |
4.33 |
$0.18 |
24.63 |
| 2013-08-31 |
4.09 |
$0.08 |
48.39 |
| 2013-05-31 |
3.74 |
$0.09 |
43.29 |
| 2013-02-28 |
3.40 |
$0.11 |
30.68 |
| 2012-11-30 |
3.72 |
$0.11 |
35.46 |
| 2012-08-31 |
3.61 |
$0.29 |
12.43 |
| 2012-05-31 |
3.17 |
$0.23 |
13.68 |
| 2012-02-29 |
3.17 |
$0.24 |
13.26 |
| 2011-11-30 |
2.41 |
$0.26 |
9.43 |
| 2011-08-31 |
2.52 |
$0.13 |
19.32 |
| 2011-05-31 |
2.27 |
$0.15 |
14.72 |
| 2011-02-28 |
2.57 |
$0.11 |
23.92 |
| 2010-11-30 |
2.32 |
$0.10 |
22.19 |
| 2010-08-31 |
1.92 |
$0.12 |
16.04 |
| 2010-05-31 |
1.88 |
$0.18 |
10.46 |
| 2010-02-28 |
1.31 |
$0.15 |
8.74 |
| 2009-11-30 |
1.10 |
$0.18 |
6.31 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
